What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Biochemistry
His primary scientific interests are in Internal medicine, Deferoxamine, Thalassemia, Surgery and Deferasirox.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Cardiology.
His biological study spans a wide range of topics, including Chelation, Chelation therapy and Chemotherapy.
His research in Thalassemia intersects with topics in Guideline, Ferritin and Intensive care medicine.
His Surgery research incorporates elements of Microcirculation, Endothelium, Deferiprone and BETA THALASSEMIA MAJOR.
His research integrates issues of Myelodysplastic syndromes, Adverse effect, Randomized controlled trial and Pediatrics in his study of Deferasirox.
His most cited work include:
- Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload (1243 citations)
- A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. (568 citations)
- Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major (399 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Thalassemia, Deferasirox, Gastroenterology and Deferoxamine.
As a member of one scientific family, John B. Porter mostly works in the field of Internal medicine, focusing on Surgery and, on occasion, Ejection fraction.
In his work, Magnetic resonance imaging is strongly intertwined with Cardiology, which is a subfield of Thalassemia.
His work deals with themes such as Adverse effect, Myelodysplastic syndromes, Creatinine, Deferiprone and Pediatrics, which intersect with Deferasirox.
His Gastroenterology research includes elements of Tolerability and Prospective cohort study.
The various areas that he examines in his Deferoxamine study include Chelation and Transferrin.
He most often published in these fields:
- Internal medicine (49.60%)
- Thalassemia (31.65%)
- Deferasirox (31.65%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (49.60%)
- Thalassemia (31.65%)
- Deferasirox (31.65%)
In recent papers he was focusing on the following fields of study:
John B. Porter mostly deals with Internal medicine, Thalassemia, Deferasirox, Gastroenterology and Blood transfusion.
His Internal medicine study integrates concerns from other disciplines, such as Oncology and Cardiology.
John B. Porter combines subjects such as Surgery, Adverse effect, Genetic enhancement and Pediatrics with his study of Thalassemia.
His Deferasirox research includes themes of Deferoxamine, Deferiprone, Renal function, Beta thalassemia and Myelodysplastic syndromes.
His Deferoxamine study frequently draws connections to adjacent fields such as Ejection fraction.
In his research, Granulocyte colony-stimulating factor is intimately related to Busulfan, which falls under the overarching field of Gastroenterology.
Between 2014 and 2021, his most popular works were:
- Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. (99 citations)
- Eltrombopag: A powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator (54 citations)
- Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders. (51 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Biochemistry
John B. Porter focuses on Internal medicine, Thalassemia, Gastroenterology, Deferasirox and Surgery.
His Internal medicine research is multidisciplinary, incorporating elements of Pathology, Immunology and Cardiology.
His Thalassemia research integrates issues from Oncology, Hematology, Anemia, Blood transfusion and Iron chelation therapy.
John B. Porter interconnects Adverse effect, Pediatrics and Liver Iron Concentration in the investigation of issues within Gastroenterology.
The study incorporates disciplines such as Deferoxamine, Deferiprone, Siderosis, Beta thalassemia and Ferritin in addition to Deferasirox.
His Surgery study combines topics from a wide range of disciplines, such as Cardiomyopathy and Magnetic resonance imaging.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
